Actinium Pharmaceuticals Inc (ATNM)
1.8000 x 18 1.8900 x 5
Post-market by (Cboe BZX)
1.8100 -0.0800 (-4.23%) 03/28/25 [NYSE Arca]
1.8000 x 18 1.8900 x 5
Post-market 1.8001 -0.0099 (-0.55%) 19:47 ET
for Fri, Mar 28th, 2025
Fiscal Year End Date: 12/31
12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 13,713 | 17,400 | 20,554 | 25,678 | 6,707 |
TOTAL | $14,330 | $17,839 | $22,391 | $26,482 | $7,407 |
Non-Current Assets | |||||
PPE Net | 119 | 57 | 89 | 106 | 128 |
Investments And Advances | 50 | 50 | 50 | 0 | 0 |
Other Non-Current Assets | 391 | 391 | 0 | 0 | 35 |
TOTAL | $560 | $498 | $138 | $106 | $162 |
Total Assets | $14,889 | $18,337 | $22,529 | $26,588 | $7,569 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 5,814 | 4,650 | 4,220 | 1,499 | 2,498 |
Other current liabilities | N/A | 16 | 301 | 2,849 | 6,710 |
TOTAL | $6,063 | $4,666 | $4,521 | $4,614 | $9,492 |
Non-Current Liabilities | |||||
TOTAL | $13 | $N/A | $N/A | $N/A | $N/A |
Total Liabilities | $6,077 | $4,666 | $4,521 | $4,614 | $9,492 |
Shareholders' Equity | |||||
Shares Outstanding, K | 3,967 | 3,670 | 1,858 | 1,478 | 1,182 |
Common Shares | 116 | 80 | 56 | 44 | 30 |
Retained earnings | -186,857 | -163,153 | -136,552 | -112,230 | -91,205 |
TOTAL | $8,813 | $13,671 | $18,008 | $21,974 | $-1,923 |
Total Liabilities And Equity | $14,889 | $18,337 | $22,529 | $26,588 | $7,569 |